et al Vancomycin-resistant enterococci. Lancet 1988; 1: 57–8.
et al Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157–61.
et al High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173–81.
et al Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76–9.
et al Genotypic characterization of a nosocomial outbreak of vanA Enterococcus faecalis. Microb Drug Res 1996; 2: 231–7.
et al Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1997; 29: 259–63.
et al Emergence of vanco-mycin-resistant enterococci in South Africa. S Afr Med J 1997; 87: 1557.
et al Vancomycin-resistant enterococci (VRE) in Canada—results of the Canadian nosocomial infection surveillance program 1996 VRE point prevalence surveillance project. Can J Infect Dis 1997; 8: 73–8.
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187–90.
et al Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999; 20: 828–33.
et al vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J Clin Microbiol 1999; 37: 3934–9.
et al The first clinical isolates of Enterococcus faecium with the VanA phenotype in a tertiary Greek hospital. J Antimicrob Chemother 2000; 46: 1039–40.
et al Molecular analysis of vanA elements from strains of Enterococcus faecium and Enterococcus faecalis isolated during the first outbreak of glycopeptide resistant enterococci in Brazil. In: Program and Abstracts of the 1st International ASM Conference on Enterococci, Banff, Alberta, Canada. Washington, DC: American Society for Microbiology, 2000., ,
Antimicrobial resistance among enterococci: A view from US clinical laboratories. In: Program and Abstracts of the 1st International ASM Conference on Enterococci, Banff, Alberta, Canada. Washington, DC: American Society for Microbiology, 2000.
et al Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. J Antimicrobial Chemother 2000; 46: 931–40.
European VRE Study Group. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. Antimicrob Agents Chemother 1999; 43: 2542–6.
, , ,
et al Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989; 33: 10–5.
Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NTCT 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195–8.
et al Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117–27.
et al In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species. Eur J Clin Microbiol Infect Dis 1996; 15: 50–9.
et al vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995; 36: 595–606.
et al Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis 1997; 16: 473–4.
et al Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997; 41: 24–9.
et al Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Inf Dis 1997; 3: 311–7.
Medical consequences of antibiotic use in agriculture. Science 1998; 279: 996–7.
Glycopeptide-resistant enterococci. A decade of experience. J Med Microbiol 1998; 47: 849–62.
Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998; 19: 539–45.
Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 1998; 19: 546–51.
et al Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 1999; 5: 329–35.
et al Vancomycin resistance: Status quo and quo vadis. Eur J Clin Microbiol Infect Dis 1999; 18: 683–90.
Epidemiology of resistance to antibiotics. Links between animals and humans. Int J Antimicrob Agents 2000; 14: 327–35.
Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion for food animals in Denmark. APMIS 2000; 108: S101.
Preface. Zoonoses. Biology, clinical practice, and public health control. Oxford: Oxford University Press, 1998: XVI–XIX., , ., eds.
Episome-mediated transfer of drug resistance in Enterobacteriaceae. I. Transfer of resistance factors by conjugation. J Bacteriol 1961; 81: 669–78.
Resistance to penicillins and its transfer in Enterobacteriaceæ. Lancet 1965; i: 407–9.
Drug resistance and its transfer in Salmonella typhimurium. Nature 1965; 206: 579–83.
Antimicrobial drugs in animal feeds. Nature 1968; 218: 728–31.
Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine. London: Her Majesty’s Stationary Office; 1969.
et al An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med 1999; 341: 1420–5.
et al Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 1991; 37: 1197–9., ,
et al Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–98. N Engl J Med 1999; 340: 1525–32.
Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature 1976; 260: 40–2.
Inter- and intraspecies spread of Escherichia coli in a farm environment in the abscence of antibiotic usage. Proc Natl Acad Sci USA 1990; 87: 6609–13.
Spread of plasmid-mediated noursethricin resistance due to antibiotic use in animal husbandry. J Basic Microbiol 1986; 8: 461–6.
The spread of plasmids as a function of bacterial adaptability. FEMS Microbiol Ecol 1994; 15: 23–31.
et al High genetic homology between plasmids of human and animal origins conferring resistance to the aminoglycosides gentamicin and apramycin. Antimicrob Agents Chemother 1991; 35: 590–3.
Characterization of a new enterococcal gene, sat G encoding a putative acetyltransferase conferring resistance to streptogramin A compounds. Antimicrob Agents Chemother 1999; 43: 1813–4.
et al Surveillance of antimicrobial resistance in bacteria isolated from food animals to growth promoters and related therapeutic agents in Denmark. APMIS 1998; 106: 606–22.
Presence of the satA gene encoding streptogramin A resistance in Enterococcus faecium from pigs and broilers. FEMS Microbiol Lett 1998; 168: 145–51.
et al Antimicrobial resistance in enterococci isolated from turkey flocks fed with virginiamycin. Antimicrob Agents Chemother 1998; 42: 705–8.
Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 1993; 342: 490–1.
et al Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett 1993; 80: 23–9.
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infections in man. J Antimicrob Chemother 1994; 34: 507–14.
et al vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995; 125: 165–71.
et al vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994; 33: 553–61.
et al Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and faecal samples of humans in the community. Microb Drug Res 1995; 1: 265–72.
Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Res 1995; 1: 255–7.
et al Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster. Antimicrob Agents Chemother 1996; 40: 1938–40.
et al Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med 1997; 31: 95–112.
et al The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production. Microb Drug Res 1999; 5: 135–9.
et al Isolation of glycopeptide-resistant enterococci from chickens in Japan. Antimicrob Agents Chemother 1998; 42: 3333.
Antimicrobial resistance on pig faecal samples from the Netherlands (five abattoirs) and Sweden. J Antimicrobial Chemother 2000; 45: 663–71.
et al Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996; 40: 2605–9.
Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited. Antimicrob Agents Chemother 1998; 42: 3049.
et al Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb Drug Res 1999; 5: 53–6.
et al Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 1999; 354: 741–2.
et al Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999; 5: 45–52.
et al Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol 2000; 89: 478–85.
et al Persistence of vancomycin-resistant enterococci (VRE) on Norwegian broiler farms. FEMS Microbiol Lett 2000; 191: 255–8.
Persistence of tetracycline resistance in pig E. coli. Nature 1975; 258: 628–30.
et al Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129–36.
et al Faecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in community in The Netherlands. J Clin Microbiol 1997; 35: 3026–31.
et al Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol 1999; 37: 3509–13.
Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558–9.
, , .
et al Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub) urban residents in the south of The Netherlands: evidence for transmission from animals to humans? Antimicrob Agents Chemother 1999; 43: 2215–21.
et al Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Inf Dis 2000; 6: 534–5.
et al Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995; 33: 2842–6.
Vancomycin-resistant enterococci at a large University hospital in Denmark. APMIS 1996; 104: 475–9.
et al Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infec 1997; 3: 175–9.
et al Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. J Clin Microbiol 2000; 38: 620–4.
et al Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 2000; 21: 520–4.
VRE and meat. Lancet 1997; 349: 1258.
et al Vancomycin-resistant enterococci in vegetarians. Lancet 1997; 350: 146–7.
et al A low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Scand J Inf Dis 1998; 30: 465–8.
et al Enterococci resistant to multiple antimicrobial agents including vancomycin. Establishment of endemicity in a University medical center. Ann Intern Med 1995; 123: 250–9.
et al Epidemiological evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol 1998; 36: 830–2.
et al Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Inf Dis 1993; 16: 750–5.
et al Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996; 40: 1526–30.
et al Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 751–2.
et al Isolation of vancomycin resistant Enterococcus faecium from food. Int J Food Microbiol 1997; 35: 57–66.
Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: Genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. J Clin Microbiol 2000; 38: 2774–7.
et al Incidence and relationship of group D streptococci with other indicator organisms in meat. Can J Microbiol 1978; 24: 1502–8.
Nosocomial enterococci. resistance to heat and sodium hypochlorite. J Hosp Inf 1995; 30: 93–199.
et al Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995; 16: 577–81.
et al Antibiotic resistant strains of Enterococcus isolated from Swedish retailed chicken and pork. J Appl Microbiol 1998; 84: 1163–70.
et al Probiotics as a source of Enterococcus Faecium[abstract 123]. Program and Abstract of the 32nd Infectious Diseases Society of America Annual Meeting, Orlando, FL. , ,
‘Enterococci in food fermentations. Functional and safety aspects’. A European Commission shared cost research project funded within the fair program. In: Program and Abstracts of the 1st International ASM Conference on Enterococci, Banff, Alberta, Canada. Washington, DC: American Society for Microbiology, 2000., ,
et al Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother 1996; 40: 2285–7.
et al Vancomycin-resistant enterococci in cats and dogs. Lancet 1996; 348: 1038–9.
et al Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms. Microb Drug Res 1998; 4: 313–8.
et al Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob Agents Chemother 1999; 43: 724–5.
Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium. Clin Microbiol Infect 1999; 5: 97–100.
et al Ingestion of vancomycin-resistant Enterococcus faecium strains of food animal origin by human healthy volunteers: a randomized double-blind study [abstract 1692 ]. In: Programs and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 2000: 432., ,
et al Characterization and identification of Enterococcus species isolated from the intestines of animals. Int J Sys Bacteriol 1987; 37: 257–9.
Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol 1993; 75: 399–408.
et al Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 2000; 182: 816–23.
Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrobial Agents Chemother 1995; 39: 2446–53.
Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother 1995; 39: 1772–8.
Arrangements of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett 1997; 155: 55–61.
Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob Agents Chemother 1997; 41: 1805–7.
et al Molecular analysis of Tn1546 in Enterococcus faecium isolates from animals and humans. Antimicrob Agents Chemother 1998; 42: 507–14., ,
et al Diversity of VanA glycopeptide resistance elements in enterococci from humans and non-human sources. Antimicrob Agents Chemother 1998; 42: 502–8.
et al Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands. J Clin Microbiol 1998; 36: 1927–32.
et al Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. Microb Drug Res 2000; 6: 49–57.
et al Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from northeastern United States. Antimicrob Agents Chemother 1995; 39: 362–8.
et alMolecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 1999; 43: 483–91.
, , ,
et al DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates. Antimicrob Agents Chemother 1998; 42: 202–5.
et al Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins. Antimicrob Agents Chemother 1999; 43: 2032–7.
Investigation by long PCR of the genetic elements mediating VanA glycopeptide resistance in enterococci from uncooked meat in South Manchester, pp. 409–12. In: Streptococci and the Host (Horaud T, Bouvet A, Leclercq R, de Montclos H, Sicard M, eds). New York: Plenum., ,
et al Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci. Biotechniques 1998; 24: 432–7.
et al Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J Antimicrob Chemother 1998; 42: 605–12.
Nucleotide sequence of IS1542, an insertion sequence identified within VanA glycopeptide resistance elements of enterococci. FEMS Microbiol Lett 1999; 173: 341–6.
Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry. Antimicrob Agents Chemother 1998; 42: 2463–4.
et al Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999; 43: 1105–10.
et al Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 2001; 45: 986–9.
Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. FEMS Microbiol Lett 2000; 185: 1–7.
Analysis of genes encoding D-alanine: D-alanine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp. Gene 1995; 152: 79–83.
et al Evolution of structure and substrate specificity in D-alanine: D-alanine ligases and related enzymes. J Mol Evol 1996; 42: 706–12.
A-alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycinresistant Leuconostoc mesenteroides. Effects of a phenylalanine 216 to tyrosine mutation. J Biol Chem 1997; 272: 9210–4.
et al D-Ala-D-Ala ligases from glycopeptide producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA 1997; 94: 6480–3.
et al Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother 1998; 42: 2215–20.
et al Modification of peptidoglycan precursors is a common feature of the low-level vancomycin resistant VanB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol 1994; 176: 2398–405.
Antibiotic preparations contain DNA. a source of drug resistance genes? Antimicrob Agents Chemother 1993; 37: 2379–84.
et al DNA sequence resembling vanA and vanB in the vancomycin resistant biopesticide Bacillus popilliae. J Infect Dis 1998; 178: 584–8.
et al The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal vanA vancomycin resistance gene cluster. Antimicrob Agents Chemother 2000; 44: 705–9.
et al Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 2000; 44: 3224–8.
Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin – United States, 1989–93. Morb Mortal Wkly Rep 1993; 42: 597–9.
et al Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280–5.
et al Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37: 2311–7.
et al Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Inf Dis 1995; 172: 993–1000.
et al Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 1994; 32: 2840–2.
Outpatient prevalence of vancomycin-resistant enterococcal (VRE) colonization in the catchment area of a hospital hyperendemic for VRE (Abstract). Infect Control Hosp Epidemiol 1996; 17: 20.
et al Patients’ endogenous flora as a source of ‘nosocomial’ vancomycin-resistant enterococci (VRE) [abstract 271]. In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Canada. Washington, DC: American Society for Microbiology, 1996., ,
Vancomycin resistance and avoparcin. Lancet 1996; 347: 1412.
Assessing the evidence that antibiotic growth promoters influence human infections. J Hosp Infect 1999; 43: 173–8.
Historical yearly usage of vancomycin. Antimicrob Agents Chemother 1998; 42: 1303–4.
et al The epidemiology of intravenous vancomycin usage in a University hospital. A 10-year study. JAMA 1993; 269: 598–602.
VanA-type glycopeptide resistant enterococci in Norway. Reservoirs – transmission – persistence. Thesis dr.med. University of Tromsø2000. ISBN-82-7589-112-4.
et al Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998; 180: 4426–34.
et al Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City hospital. Microb Drug Res 1999; 5: 113–29.
Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). The Use of Antibiotics in Food-Producing Animals: Antibiotic-Resistant Bacteria in Animals and Humans. Australia: Commonwealth Department of Health and Aged Care. Commonwealth Department of Agriculture, Fisheries and Forestry, 1999.
ancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link? Med J Aust 1999; 171: 144–6.
Australia’s antibiotic burden. Microbiol Aust 1996; 17: 11. &
et al Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother 1990; 34: 1875–9.
Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium. J Clin Microbiol 1999; 37: 2383–4.
et al Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid. Gene 1996; 171: 9–17.
et al In vivo transfer of the vanA gene cluster in the intestinal tract of germfree animals. Clin Microbiol Infect 1999; 5: 121., ,
et al Transferability of macrolide, lincomycin, and streptogramin resistances between group A, B, and D streptococci, Streptococcus pneumoniae, and Staphylococcus aureus. J Bacteriol 1980; 142: 407–13.
Conjugative transfer of R-plasmids from Streptococcus faecalis to Staphylococcus aureus. Antimicrob Agents Chemother 1982; 22: 204–7.
Antimicrobial resistance in Staphylococcus aureus: Genetic basis. Microbiol Rev 1987; 51: 88–134.
The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46–65.
et al Streptococcus faecalis sex pheromone (cAM373) also produced by Staphylococcus aureus and identification of a conjugative transposon (Tn918). J Bacteriol 1985; 162: 1212–20.
Why does Staphylococcus aureus secrete an Enterococcus faecalis-specific pheromone? FEMS Microbiol Lett 1997; 157: 261–6.
, , .
Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet 1997; 349: 997–8.
et al Persistence of antibacterial agents in marine sediments. Aquaculture 1995; 133: 175–84.
et al Degradation of the fluoroquinolone enrofloxacin by wood-rotting fungi. Appl Environ Microbiol 1996; 62: 4206–9.
Structural modification of glycopeptide antibiotics. Med Res Rev 1997; 117: 69–113.
Degradation of ciprofloxacin by basidiomycetes and identification of metabolites by the brown rot fungus Gloeophyllum striatum. Appl Environ Microbiol 1999; 65: 1556–63.
, , , ,
et al Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect 2000; 6: 477–82.
Will avilamycin convert Ziracine into Zerocine? Emerg Infect Dis 2000; 6: 558.
Antibiotics, animals, and people-again! Science 2001; 291: 397.
Casting pills before swine. Newsweek 2001, January 22, 2.
The medical impact of the use of antimicrobials in food animals.Report from a WHO Meeting; Berlin, Germany 1997 October 13–17. Geneva: World Health Organization, 1997.
et al Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43: 2823–30.
Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 2000; 64: 672–93.
Resistance gene capture. Curr Opin Microbiol 1999; 2: 483–8.
Integrons: novel DNA elements which capture genes by site-specific recombination. Genetica 1993; 90: 115–32.
An integron of class 1 is present on the plasmid pCG4 from Gram-positive bacterium Corynebacterium glutamicum. FEMS Microbiol Lett 1998; 169: 391–5.
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella enterica Typhimurium DT104. Microb Drug Res 1998; 4: 113–8.
Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104. FEMS Microbiol Lett 1998; 170: 37–41.
Molecular characterization of an antibiotic resistance gene cluster in Salmonella typhimurium DT104. Antimicrob Agents Chemother 1999; 43: 846–9.